Reset filter
Nyckelord
Visa mer Nyckelord
Innehållsförteckning
  1. 1. Klinisk studie
  2. 2. Rutindokumentation
  3. 3. Register- och kohortstudier
  4. 4. Kvalitetssäkring
  5. 5. Datastandard
  6. 6. Frågeformulär för patienter
  7. 7. Medicinsk specialitet
    1. 7.1. Anestesi
    1. 7.2. Dermatologi
    1. 7.3. HNO
    1. 7.4. Geriatrik
    1. 7.5. Gynekologi och obstetrik
    1. 7.6. Invärtes medicin
      1. Hematologi
      1. Infektionssjukdomar
      1. Kardiologi och angiologi
      1. Pneumologi
      1. Gastroenterologi
      1. Nefrologi
      1. Endokrinologi och ämnesomsättning
      1. Reumatologi
    1. 7.7. Neurologi
    1. 7.8. Oftalmologi
    1. 7.9. Palliativ medicin
    1. 7.10. Patologi och rättsmedicin
    1. 7.11. Pediatrik
    1. 7.12. Psykiatri och psykosomatik
    1. 7.13. Radiologi
    1. 7.14. Kirurgi
      1. Allmänkirurgi och bukkirurgi
      1. Neurokirurgi
      1. Plastikkirurgi
      1. Hjärt- och thoraxkirurgi
      1. Akutkirurgi och ortopedi
      1. Kärlkirurgi
    1. 7.15. Urologi
    1. 7.16. Odontologi samt mun-, käk och ansiktskirurgi
Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

185 Sökresultat.
Relevans Bedömning Nya först Gamla först

On-Study - Advanced Melanoma-On-study Form - 2020195v2.31 - Advanced Melanoma-On-study Form

- 2015-01-08 - 1 Formulär, 7 Item-grupper, 67 Dataelement, 1 Språk
Item-grupper: CRF Header, MELANOMA: FORM ADMINISTRATION, MELANOMA (ADVANCED): DISEASE DESCRIPTION, MELANOMA (ADVANCED): SENTINEL NODE BIOPSY, MELANOMA (ADVANCED): PRIOR TREATMENT, MELANOMA: PRIOR TREATMENT-SYSTEMIC REGIMENS, Comments
Advanced Melanoma-On-study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99CD59C5-A996-3FA4-E034-080020C9C0E0

Melanoma (Skin) NCT01274338 On-Study Form - Hematology/Chemistry On-Study Form Melanoma E1609 NCT01274338

- 2015-03-25 - 1 Formulär, 2 Item-grupper, 31 Dataelement, 1 Språk
Item-grupper: Header, ON TREATMENT
E1609 Hematology/Chemistry Form Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery NCT01274338 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=97E7C12F-E851-FFC2-E040-BB89AD43160A

Eligibility Melanoma NCT02475213

- 2019-05-08 - 1 Formulär, 2 Item-grupper, 17 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Safety Study of MGA271 in Combination With Pembrolizumab in Refractory Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02475213

Eligibility Melanoma NCT02381314

- 2019-05-07 - 1 Formulär, 2 Item-grupper, 13 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Safety Study of MGA271 in Combination With Ipilimumab in Refractory Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02381314

On-Study - Local-Regional Melanoma-On-study Form - 2020196v2.31 - Local-Regional Melanoma-On-study Form

- 2015-01-08 - 1 Formulär, 7 Item-grupper, 61 Dataelement, 1 Språk
Item-grupper: CRF Header, MELANOMA: FORM ADMINISTRATION, MELANOMA: DISEASE DESCRIPTION, MELANOMA: SENTINEL NODE BIOPSY, MELANOMA: PRIOR TREATMENT, MELANOMA: PRIOR TREATMENT-SYSTEMIC REGIMENS, Comments
Local-Regional Melanoma-On-study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99CD59C5-A998-3FA4-E034-080020C9C0E0

On-Study Form Advanced Melanoma E2603 NCT00110019

- 2021-09-20 - 1 Formulär, 7 Item-grupper, 62 Dataelement, 1 Språk
Item-grupper: Header, Patient demographics, Data amendment, Description of Disease at Initial Diagnosis, History of Disease, Description of Current Disease, Comments
E2603 Advanced Melanoma On-Study Form NCT00110019 Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma E2603 Advanced Melanoma On-Study Form NCT00110019 Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E75E3DD6-DB7A-4ABA-E034-0003BA3F9857

Follow-Up - Melanoma-Follow-up Form - 2020198v2.31 - Melanoma-Follow-up Form

- 2015-01-08 - 1 Formulär, 8 Item-grupper, 33 Dataelement, 1 Språk
Item-grupper: CRF Header, MELANOMA: VITAL STATUS, MELANOMA: DISEASE FOLLOW-UP STATUS, MELANOMA: NOTICE OF PROGRESSION, MELANOMA: NON-PROTOCOL THERAPY, MELANOMA: NOTICE OF NEW PRIMARY, MELANOMA: LONG-TERM TOXICITY, Comments
Melanoma-Follow-up Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99CD59C5-A99C-3FA4-E034-080020C9C0E0

Prestudy Form Adjuvant Melanoma SWOG S0201

- 2015-07-25 - 1 Formulär, 4 Item-grupper, 24 Dataelement, 1 Språk
Item-grupper: SWOG clinical trial administrative data, Patient Characteristics, HLA Status, Primary Tumor
Southwest Oncology Group S0201 Adjuvant Melanoma Prestudy Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A8B98176-F2DC-123A-E034-0003BA12F5E7

Southwest Oncology Group S0201 Adjuvant Melanoma Follow Up

- 2015-07-03 - 1 Formulär, 7 Item-grupper, 31 Dataelement, 1 Språk
Item-grupper: SWOG clinical trial administrative data, Vital Status, Disease Follow-up Status, Notice of First Relapse or Progression, Notice of New Primary, Non-Protocol Treatment, CCRR MODULE
Southwest Oncology Group S0201 Adjuvant Melanoma Follow Up Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A8BA0178-CF14-0F96-E034-0003BA12F5E7

dbGaP phs001005 Antigen Discovery in Melanoma - pht005038.v2.p1

- 2023-10-14 - 4 Formulär, 1 Item-grupp, 3 Dataelement, 1 Språk
Item-grupp: pht005038
Principal Investigator: Richard Wilson, McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA MeSH: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001005 This study of three metastatic melanoma patients utilized exome sequencing and RNA sequencing to help identify putative neoantigen peptides that could be further validated by standard immunological assays before design of a personalized vaccine. For each set of neoantigens identified and verified by standard assays, we designed GMP peptides that correspond to the top neoantigens, then used these to condition dendritic cell isolates from each patient. The conditioned dendritic cells were used as the vaccine in three rounds of vaccination, followed by monitoring for T cell memory response to each of the neoantigens.

pht005040.v2.p1

1 Item-grupp 2 Dataelement

pht005039.v2.p1

1 Item-grupp 2 Dataelement

pht005041.v2.p1

1 Item-grupp 6 Dataelement

Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162 - Yearly Follow-up contact; Anti Cancer Therapy (Report Final and Annex Report 2 Final)

- 2020-10-30 - 1 Formulär, 5 Item-grupper, 11 Dataelement, 1 Språk
Item-grupper: Adminstrative, Yearly Follow-up - Check for Follow-up contact, End of yearly Follow-up contact, Anti-cancer therapy(ies) following last study treatment administration, Subsequent treatment
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma

Melanoma (Skin) null Follow-Up - Missed Visit (MV) - 2074838v3.0 - Missed Visit (MV)

- 2015-01-09 - 1 Formulär, 1 Item-grupp, 10 Dataelement, 1 Språk
Item-grupp: CCRR MODULE
Missed Visit (MV) Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B12440AB-9301-4E9E-E034-0003BA12F5E7

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial